Business

Pfizer releases new data showing that side effects are similar to a second dose

Healthcare workers will receive a third dose of the Pfizer-BioNTech Covid-19 vaccine at the Elderly Living Facility in Worcester, PA, on Wednesday, August 25, 2021.

Hannah Bayer | Bloomberg | Getty Images

Pfizer is seeking approval to distribute booster shots nationwide, so new data submitted to the Food and Drug Administration show that the side effects of Covid booster shots are similar to those felt after the second dose and are younger. He said it is likely to affect people.

In a Phase 3 trial of Pfizer’s booster dose, which included a group of approximately 300 participants between the ages of 18 and 55, 63.7% experienced fatigue after obtaining the booster, and 48.4% experienced headache. It was found that 39.1% felt muscle pain. Most of the responses to boosters were mild or moderately severe, the company said in a 52-page report released by authorities on Wednesday. The company, along with BioNTech, is seeking FDA urgent approval for a third dose to people over the age of 16 across the United States.

Pfizer previously evaluated the side effects of 2,682 people aged 16-55 years who received a second dose, with 61.5% developing fatigue, 54% suffering from headaches, and 39.3% coping with myalgia. I found that.

The study also followed adverse events among 306 booster immune recipients, 44 of whom developed at least one unexpected side effect. The most common adverse event, lymph node swelling, was seen in 16 participants.

Pfizer releases new data showing that side effects are similar to a second dose

Source link Pfizer releases new data showing that side effects are similar to a second dose

Back to top button